Alpha Teknova, Inc. (NASDAQ:TKNO) Major Shareholder Telegraph Hill Partners Iv, L. Buys 12,096,773 Shares

Alpha Teknova, Inc. (NASDAQ:TKNO) major shareholder Telegraph Hill Partners Iv, L. purchased 12,096,773 shares of the stock in a transaction dated Friday, July 12th. The shares were bought at an average price of $1.24 per share, for a total transaction of $14,999,998.52. Following the completion of the acquisition, the insider now owns 11,126,929 shares in the company, valued at $13,797,391.96. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Alpha Teknova Stock Performance

NASDAQ:TKNO traded up $0.07 during trading hours on Tuesday, hitting $1.35. 110,760 shares of the company traded hands, compared to its average volume of 23,324. The company has a current ratio of 5.52, a quick ratio of 3.92 and a debt-to-equity ratio of 0.16. Alpha Teknova, Inc. has a twelve month low of $1.16 and a twelve month high of $4.27. The firm has a 50-day moving average of $1.59 and a 200 day moving average of $2.40. The stock has a market capitalization of $55.11 million, a price-to-earnings ratio of -1.29 and a beta of 0.34.

Alpha Teknova (NASDAQ:TKNO) last announced its quarterly earnings data on Monday, May 13th. The company reported ($0.20) EPS for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.04. Alpha Teknova had a negative net margin of 97.85% and a negative return on equity of 38.24%. The business had revenue of $9.29 million during the quarter, compared to analyst estimates of $7.80 million. During the same quarter in the prior year, the business earned ($0.31) earnings per share. On average, analysts forecast that Alpha Teknova, Inc. will post -0.65 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Stephens restated an “overweight” rating and set a $5.00 price target on shares of Alpha Teknova in a report on Wednesday, July 10th.

Institutional Trading of Alpha Teknova

A number of hedge funds have recently modified their holdings of TKNO. Fielder Capital Group LLC acquired a new stake in shares of Alpha Teknova during the 4th quarter valued at about $156,000. Conestoga Capital Advisors LLC boosted its holdings in Alpha Teknova by 4.1% during the fourth quarter. Conestoga Capital Advisors LLC now owns 247,529 shares of the company’s stock valued at $923,000 after purchasing an additional 9,800 shares in the last quarter. State Board of Administration of Florida Retirement System bought a new stake in shares of Alpha Teknova in the 1st quarter valued at approximately $35,000. FourWorld Capital Management LLC acquired a new position in shares of Alpha Teknova in the 1st quarter worth approximately $135,000. Finally, Redmile Group LLC lifted its position in shares of Alpha Teknova by 6.5% during the 1st quarter. Redmile Group LLC now owns 171,453 shares of the company’s stock worth $434,000 after buying an additional 10,448 shares during the period. Institutional investors own 13.81% of the company’s stock.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.